We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$102B
AUM Growth
+$4.89B
(+5%)
Cap. Flow
-$14.3B
Cap. Flow
% of AUM
-14.05%
Top 10 Holdings %
Top 10 Hldgs %
21.48%
Holding
2,932
New
37
Increased
642
Reduced
1,943
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$442M |
| 2 |
SLB Ltd
SLB
|
+$418M |
| 3 |
Verizon
VZ
|
+$404M |
| 4 |
Bank of America
BAC
|
+$370M |
| 5 |
Rockwell Automation
ROK
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
UnitedHealth
UNH
|
+$646M |
| 3 |
CrowdStrike
CRWD
|
+$621M |
| 4 |
Marvell Technology
MRVL
|
+$617M |
| 5 |
Apple
AAPL
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.33% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 8.56% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Karyopharm Therapeutics
KPTI
$46.7M
| $58.6K | ﹤0.01% |
2,587
-444
| -15% | -$7.79K |
|
2577
Erasca
ERAS
$6.6B
| $58.4K | ﹤0.01% |
28,371
-5,928
| -17% | -$11.8K |
|
|
PPTA
2578
Perpetua Resources
PPTA
$3.18B
| $58.3K | ﹤0.01% |
14,007
-3,165
| -18% | -$10.4K |
|
2579
Kodiak Sciences
KOD
$2.72B
| $57.7K | ﹤0.01% |
10,966
-5,235
| -32% | -$25.6K |
|
2580
HF Foods Group
HFFG
$99.2M
| $56.9K | ﹤0.01% |
16,258
-2,513
| -13% | -$11K |
|
2581
X4 Pharmaceuticals
XFOR
$446M
| $56.4K | ﹤0.01% |
1,353
-289
| -18% | -$8.04K |
|
2582
Rimini Street
RMNI
$443M
| $56.1K | ﹤0.01% |
17,211
-3,342
| -16% | -$10.7K |
|
|
ME
2583
DELISTED
23andMe Holding Co
ME
| $55.8K | ﹤0.01% |
5,245
-270,622
| -98% | -$3.48M |
|
2584
BlackSky Technology
BKSY
$1.29B
| $55.5K | ﹤0.01% |
5,098
-911
| -15% | -$10K |
|
|
SRTA
2585
Strata Critical Medical Inc
SRTA
$527M
| $55.4K | ﹤0.01% |
19,433
-5,549
| -22% | -$17.1K |
|
2586
BRC Inc
BRCC
$216M
| $55.3K | ﹤0.01% |
12,909
-2,296
| -15% | -$9.52K |
|
|
LICY
2587
DELISTED
Li-Cycle Holdings Corp.
LICY
| $53.3K | ﹤0.01% |
6,464
-476
| -7% | -$2.14K |
|
2588
Ring Energy
REI
$354M
| $53.1K | ﹤0.01% |
27,115
| – | – |
|
2589
Nautilus Biotechnolgy
NAUT
$113M
| $53K | ﹤0.01% |
18,017
-3,409
| -16% | -$9.67K |
|
2590
Aldeyra Therapeutics
ALDX
$93.5M
| $52.6K | ﹤0.01% |
16,086
-3,248
| -17% | -$10.7K |
|
2591
Blink Charging
BLNK
$86.5M
| $52.5K | ﹤0.01% |
17,454
-3,751
| -18% | -$10.6K |
|
2592
BioAtla
BCAB
$5.59M
| $50.9K | ﹤0.01% |
296
-61
| -17% | -$7.58K |
|
2593
Amylyx Pharmaceuticals
AMLX
$2.66B
| $49.3K | ﹤0.01% |
17,357
-2,818
| -14% | -$36.9K |
|
2594
ThredUp
TDUP
$407M
| $49.1K | ﹤0.01% |
24,565
-4,579
| -16% | -$9.34K |
|
|
BHR
2595
Braemar Hotels & Resorts
BHR
$140M
| $48.8K | ﹤0.01% |
24,417
-4,265
| -15% | -$9.42K |
|
2596
Eos Energy Enterprises
EOSE
$1.54B
| $47.9K | ﹤0.01% |
46,546
+1,738
| +4% | +$1.77K |
|
2597
Adicet Bio
ACET
$77.4M
| $47.6K | ﹤0.01% |
+1,267
| New | +$52.4K |
|
|
TSE
2598
DELISTED
Trinseo
TSE
| $47.3K | ﹤0.01% |
12,514
-2,253
| -15% | -$12K |
|
2599
DHI Group
DHX
$175M
| $46.9K | ﹤0.01% |
18,393
-1,470
| -7% | -$3.67K |
|
2600
Emergent Biosolutions
EBS
$231M
| $46.9K | ﹤0.01% |
18,520
-1,544
| -8% | -$3.48K |
|
Similar funds
VAM
VOYA Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, VOYA Investment Management held 2,932 positions worth $102B, up 5% from $97.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
VOYA Investment Management withdrew a net $14.3B in Q1 2024, closing 149 positions and reducing 1,943 holdings. Its most notable exit was Cameco, an estimated $69.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, VOYA Investment Management opened a new position in T. Rowe Price Capital Appreciation Equity ETF worth $86.5M.
- VOYA Investment Management's largest Q1 2024 buy was T. Rowe Price Capital Appreciation Equity ETF: 2,861,296 shares worth $86.5M.
- VOYA Investment Management added most to GE Aerospace in Q1 2024, an estimated $442M increase.
- VOYA Investment Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.29B.
- VOYA Investment Management fully exited Cameco in Q1 2024, selling an estimated $69.1M.
- VOYA Investment Management's ten largest holdings make up 21% of its $102B portfolio in Q1 2024.
- VOYA Investment Management opened 37 new positions and closed 149 in Q1 2024.
- VOYA Investment Management's portfolio value rose 5% quarter-over-quarter to $102B.
Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.